Approvals
After US approval, Amylyx faces regulatory hurdle in Europe for ALS treatment
Relyvrio is once again at the heart of another debate over ALS trial endpoints; this time in Europe.
Relyvrio is once again at the heart of another debate over ALS trial endpoints; this time in Europe.